Azzad Asset Management Inc /Adv Bio Techne Corp Transaction History

Azzad Asset Management Inc /Adv

$848 Billion
Q2 2024

A detailed history of Azzad Asset Management Inc /Adv transactions in Bio Techne Corp stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 44,638 shares of TECH stock, worth $3.23 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

44,638

Previous 44,570 0.15%

Holding current value

$3.23 Million

Previous $3.14 Billion 1.94%

% of portfolio

0.38%

Previous 0.37%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$62.12 - $84.15 $4,224 - $5,722	68 Added 0.15%	44,638 $3.2 Billion
Q1 2024 Apr 19, 2024	BUY	$65.98 - $77.09 $67,497 - $78,863	1,023 Added 2.35%	44,570 $3.14 Billion
Q4 2023 Apr 01, 2024	BUY	$52.83 - $78.22 $252,897 - $374,439	4,787 Added 12.35%	43,547 $3.36 Billion
Q3 2023 Apr 01, 2024	BUY	$67.52 - $89.42 $529,424 - $701,142	7,841 Added 25.36%	38,760 $2.64 Billion
Q2 2023 Apr 01, 2024	BUY	$73.76 - $85.98 $226,516 - $264,044	3,071 Added 11.03%	30,919 $2.52 Billion
Q1 2023 Apr 01, 2024	BUY	$71.62 - $86.62 $1.15 Million - $1.39 Million	15,997 Added 134.98%	27,848 $2.07 Billion
Q4 2022 Apr 01, 2024	BUY	$80.67 - $352.29 $188,122 - $821,540	2,332 Added 24.5%	11,851 $982 Million
Q3 2022 Apr 01, 2024	BUY	$282.54 - $391.85 $15,822 - $21,943	56 Added 0.59%	9,519 $2.64 Billion
Q2 2022 Apr 01, 2024	BUY	$322.67 - $449.65 $1.08 Million - $1.51 Million	3,353 Added 54.88%	9,463 $3.02 Billion
Q1 2022 Apr 01, 2024	BUY	$353.85 - $487.79 $50,246 - $69,266	142 Added 2.38%	6,110 $2.65 Billion
Q4 2021 Apr 01, 2024	SELL	$456.15 - $525.06 $214,390 - $246,778	-470 Reduced 7.3%	5,968 $3.09 Billion
Q3 2021 Apr 01, 2024	SELL	$444.87 - $538.88 $12,011 - $14,549	-27 Reduced 0.42%	6,438 $3.12 Billion
Q2 2021 Apr 01, 2024	SELL	$387.35 - $450.26 $256,038 - $297,621	-661 Reduced 9.28%	6,465 $2.91 Billion
Q1 2021 Apr 01, 2024	SELL	$314.62 - $411.0 $10,382 - $13,563	-33 Reduced 0.46%	7,126 $2.72 Billion
Q4 2020 Apr 01, 2024	BUY	$246.9 - $321.87 $499,972 - $651,786	2,025 Added 39.44%	7,159 $2.27 Billion
Q3 2020 Apr 01, 2024	BUY	$232.22 - $282.96 $467,458 - $569,598	2,013 Added 64.5%	5,134 $1.27 Billion
Q2 2020 Apr 01, 2024	BUY	$185.43 - $279.56 $43,390 - $65,417	234 Added 8.11%	3,121 $824 Million
Q1 2020 Apr 01, 2024	SELL	$161.17 - $221.51 $475,451 - $653,454	-2,950 Reduced 50.54%	2,887 $547 Million
Q4 2019 Apr 01, 2024	BUY	$189.68 - $222.09 $46,092 - $53,967	243 Added 4.34%	5,837 $1.42 Billion
Q3 2019 Apr 01, 2024	BUY	$183.56 - $216.72 $617,312 - $728,829	3,363 Added 150.74%	5,594 $1.31 Billion
Q2 2019 Apr 01, 2024	SELL	$188.72 - $215.43 $6,982 - $7,970	-37 Reduced 1.63%	2,231 $465 Million
Q1 2019 Apr 01, 2024	SELL	$136.09 - $200.44 $6,396 - $9,420	-47 Reduced 2.03%	2,268 $450 Million
Q4 2018 Apr 01, 2024	BUY	$132.75 - $203.8 $43,674 - $67,050	329 Added 16.57%	2,315 $335 Million
Q3 2018 Apr 01, 2024	BUY	$147.44 - $204.11 $292,815 - $405,362	1,986 New	1,986 $405 Million

Others Institutions Holding TECH

# of Institutions

604

Shares Held

153M

Call Options Held

171K

Put Options Held

56.9K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.84B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Account

Azzad Asset Management Inc /Adv Bio Techne Corp Transaction History